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Introduction
Bone and soft tissue tumors are pitfalls in general ortho-
pedic practice. Early diagnosis of the disease can lead
to effective treatment strategy and significantly improve
patient outcome.1 In daily orthopedic practice, hip and
groin pain are commonly attributed to arthritis or soft
tissue inflammation.2 An unusual pain pattern will com-
monly alert the clinician to underlying malignancies
but not to metabolic bone disease. When multiple osteo-
lytic lesions are seen on plain films, routine studies
such as serum electrolyte and parathyroid hormone
(PTH) levels are often neglected as suspicion of meta-
static bone malignancies directly leads attending
physicians to tumor survey imaging studies. We herein
present a case of parathyroid adenoma and subsequent
brown tumor of the bone that presented with persis-
tent bone pain and that was initially misdiagnosed as
metastatic bone tumor.
Case Report
A 67-year-old male who had been a farmer for decades
visited our office complaining of persistent right groin
pain, left thigh pain and left upper arm soreness for
over 2 years. He had been diagnosed with right hip
joint osteoarthritis by a local health care provider.
Nonsteroidal anti-inflammatory drugs had been pre-
scribed, but there was only slight relief of the symp-
toms. Follow-up X-ray taken at a local hospital showed
multiple osteolytic lesions in the pelvic area. He was
referred to our institution under the impression of
metastatic bone tumor.
The patient’s medical history was significant only
for thalassemia minor. The pain had been persistent and
progressing with variable severity. Visual analog scale
pain score ranged from 5 to 7; the pain was exagger-
ated when walking or standing, but was slightly better
when lying in bed. The pain disturbed him during sleep
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from time to time. On physical examination, Patrick test
was positive for right hip, and mild limping gait was
noted. There was no local tenderness or pattern of radi-
ation. No neurovascular deficit was identified. Serial
plain film examination revealed multiple well-defined
pure osteolytic lesions in the pelvic girdle and both
proximal femoral shafts, as well as in the skull (salt-
and-pepper pattern) and left humeral shaft (Figure 1).
Considering the patient’s old age and the clinical
manifestations, serial imaging and laboratory studies
were conducted in light of the possibility of multiple
bony metastatic lesions. Magnetic resonance imaging
of the pelvis showed low signals on both T1-weighted
and T2-weighted images of multiple pure osteolytic
lesions. Whole-body bone scan showed multiple up-
takes over the skull, left humerus, the pelvic girdle and
the ribs (Figure 2). Although all of the above findings
indicated metastatic bone tumor, the levels of tumor
markers (α-fetoprotein, prostate-specific antigen, car-
cinoembryonic antigen) were all within normal limits.
Computed tomography of the chest and abdomen to
search for the tumor origin showed no abnormalities.
At this point, all the clinical evidence rationally indi-
cated a diagnosis of metastasis of unknown origin.
Laboratory studies, however, unveiled the differ-
ential diagnosis of metabolic bone disease. Blood cell
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Figure 1. Multiple osteolytic lesions on X-ray examination. (A) Lesions in proximal femurs and pelvic girdle (arrows). (B) Lesions in left
humeral shaft (arrows). (C) Typical salt-and-pepper pattern of brown tumor on the skull (arrows).
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Figure 2. (A) Whole-body bone scan reveals increased uptake in the skeleton. (B) Magnetic resonance image is compatible with multiple
osteolytic lesions (arrows).
counts and routine biochemical analyses were normal
except for an elevated serum calcium level of 14.3
mg/dL, which led to the consideration of underlying
hyperparathyroidism. Subsequent check-ups revealed
a high intact-PTH level of 986 pg/mL. For the pur-
poses of ruling out the cause of hyperparathyroidism,
sonographic examination was performed and revealed
an adenoma, 2.8 cm in diameter, in the right parathy-
roid gland. Taking account of the new evidence, brown
tumor caused by parathyroid adenoma was considered
the most likely diagnosis.
To reach the final diagnosis, pathologic analysis was
essential. At the same time, the impending pathologic
fracture of the patient’s left femur was of concern. We
therefore performed surgery for the following 2 rea-
sons: (1) to obtain tissue from the lesions for a definite
diagnosis; (2) to provide rigid internal fixation to pre-
vent fracture. Subsequent pathologic analysis confirmed
the diagnosis of brown tumor (Figure 3). Internal fix-
ation with dynamic compression plate and cemented
intramedullary pins was performed successfully. The
patient was then able to ambulate with normal gait
and without pain.
A general surgeon was consulted and performed
right-side parathyroidectomy. Two weeks postopera-
tively, the serum levels of calcium and PTH had 
declined to within their normal ranges. The multiple
osteolytic lesions resolved, and the patient was symptom-
free at the latest follow-up visit.
Discussion
Brown tumor, also known as generalized osteitis fibrosa
cystica or Von Recklinghausen disease of the bone,
comprises only a small percentage of osteolytic bony
pathologies.3 It is caused by hyperparathyroidism,
which may be primary, secondary or tertiary. Primary
parathyroidism due to parathyroid adenoma is one of
the leading causes of brown tumor. In our case, the
increased secretion of intact-PTH from the parathy-
roid adenoma triggered high osteoclast turnover activity,
leading to multiple pure osteolytic lesions.4
Metastatic bone tumor is a rational consideration
for every clinician whenever multiple osteolytic lesions
are found. It would be logical to complete a tumor
survey including bone scan, chest and abdominal imag-
ing and relevant laboratory studies including cell
counts, biochemical analyses and tumor marker lev-
els.5,6 However, since other etiologies such as multiple
myeloma or brown tumor should also be considered,7,8
serum phosphate, calcium and PTH levels and serum
protein electrophoresis should be checked before the
whole set of tumor survey is initiated. In our case, the
increased uptake on whole-body bone scan and lack
of albumin/globulin ratio reversal rendered multiple
myeloma less likely. The significantly elevated serum
calcium level was a clue that pointed toward metabolic
bone disease.9 Although hypercalcemia with high intact-
PTH level and imaging evidence of parathyroid ade-
noma all indicated that brown tumor was highly
possible, it was only with pathologic proof after surgical
biopsy that a definite diagnosis was reached.
From an orthopedic point of view, the risk of patho-
logic fracture is of concern when the brown tumor
corrupts over 2 thirds of the cortex of the long bone,
especially in the weight-bearing area.10 In our patient,
the current practice standard of preventive internal fix-
ation with bone cement augmentation was performed
to manage the impending fracture. Open biopsy was
done concurrently for diagnosis. The remaining brown
tumors were expected to resolve after treatment of the
primary hyperparathyroidism.11,12 Preventive internal
fixation is not indicated if the tumor does not involve
more than two-thirds of the weight-bearing long bone
cortex.
The importance of accurate diagnosis cannot be
overemphasized. The patient would have been treated
with chemotherapy if the diagnosis had been metastasis
of unknown origin. This would have not only left the
true problems unsolved but also harmed the patient.
Instead, with the correct diagnosis of brown tumor
caused by parathyroid adenoma, the key treatment
was excision of the adenoma. Except for impending
pathologic fracture, the multiple osteolytic lesions re-
quire no further orthopedic surgery since they would
resolve following normalization of serum intact-PTH
level.
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Brown tumor mimicking metastatic bone tumor
Figure 3. Pathology of the tumor sample taken from the patient’s
left femur. The center of the brown tumor contains osteoclasts,
mononuclear cells and fibroblasts. Focal hemorrhage containing
hemosiderin produces the grossly brown color.
Accordingly, we summarize the keystones of accu-
rately diagnosing the rarely seen brown tumor as fol-
lows. First, be highly alert. Always review the patient’s
profile and laboratory data. Serum phosphate, calcium
and PTH levels and serum protein electrophoresis
should be included in routine survey for multiple osteo-
lytic lesions. Second, brown tumor should always be
on the clinician’s list of differential diagnoses when
multiple osteolytic lesions are encountered.
We have reported a case of rarely seen metabolic
bony pathology mimicking the presentation of meta-
static bone tumor. Accurate diagnosis enabled the
proper treatment to be carried out, avoiding unneces-
sary harm to the patient. The patient became free from
the fear of malignancies, and the risk of pathologic
fractures was also diminished.
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